Urdhva Raval

Urdhva Raval

Auto-generated profile, based on publicly available information

Urdhva Raval

Icahn School of Medicine at Mount Sinai, Center for Molecular Integrative Neuroresilience New York NY USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2020 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
SNSean X. Naughton
Sean X. Naughton
URUrdhva Raval
Urdhva Raval
Giulio PasinettiGiulio Pasinetti
Giulio Pasinetti
There are a number of potential implications for the field of Alzheimer’s disease (AD) stemming from the global spread of SARS-CoV-2. Neuroinflammation is known to be a prominent feature of neurodegeneration and plays a major role in AD pathology. Im

27 June 2020 in Expert Review of Neurotherapeutics
Verified
Journal Article
Closed access
URUrdhva Raval
Urdhva Raval
JHJoyce M. Harary
Joyce M. Harary
EZEmma Zeng
Emma Zeng
Giulio PasinettiGiulio Pasinetti
Giulio Pasinetti
Age related neurodegenerative disorders affect millions of people around the world. The role of the gut microbiome (GM) in neurodegenerative disorders has been elucidated over the past few years. D...

Verified
Journal Article
Open access
PDF file
SNSean Naughton
Sean Naughton
URUrdhva Raval
Urdhva Raval
Giulio PasinettiGiulio Pasinetti
Giulio Pasinetti
Early diagnosis of Alzheimer’s disease (AD) and the identification of significant risk factors are necessary to better understand disease progression, and to develop intervention-based therapies prior to significant neurodegeneration. There is thus a critical need to establish biomarkers which can predict the risk of developing AD before the onset of cognitive decline. A number of studies have indicated that exposure to various microbial pathogens can accelerate AD pathology. Additionally, several studies have indicated that amyloid-β possess antimicrobial properties and may act in response to infection as a part of the innate immune system. These findings have led some to speculate that certain types of infections may play a significant role in AD pathogenesis. In this review, we will provide an overview of studies which suggest pathogen involvement in AD. Additionally, we will discuss a number of pathogen-associated biomarkers which may be effective in establishing AD risk. Infections that increase the risk of AD represent a modifiable risk factor which can be treated with therapeutic intervention. Pathogen-based biomarkers may thus be a valuable tool for evaluating and decreasing AD risk across the population.

21 July 2020 in Molecular Immunology
Verified
Journal Article
Open access
JWJun Wang
Jun Wang
JBJennifer Blaze
Jennifer Blaze
FHFatemeh Haghighi
Fatemeh Haghighi
SKSeunghee Kim-Schulze
Seunghee Kim-Schulze
URUrdvha Raval
Urdvha Raval
Giulio PasinettiGiulio Pasinetti
Giulio Pasinetti
Recent studies suggest that microbiome derived 3(3,4-dihydroxy-phenyl) propionic acid (DHCA) attenuates IL-6 cytokine production through downregulation of the epigenetic modifier DNA Methyltransferase 1 (DNMT1) expression and inhibition of DNA methylation at the 5’—C—phosphate—G—3’ (CpG)-rich IL6 sequence introns 1 and 3 in a mouse model of depression. In this study, we extended the investigation of DHCA epigenetic mechanisms in IL-6 expression in human peripheral blood mononuclear cells (PBMC). Using Lucia Luciferase reporter gene system we identified CpG-rich sequences in which of methylation is influenced by DHCA similar to what observed in response to treatment with the DNA methylation inhibitor 5-aza-2′-deoxycytidine. Correlation study showed that DNA methylation at select CpG motifs in the IL-6 promoter correlates with IL-6 gene expression. Our study suggests that DHCA is effective in reducing IL-6 expression in human PBMCs, in part, by regulation of methylation in the IL-6 promoter region.

12 May 2020 in Journal of Exposure Science & Environmental Epidemiology
Verified
Journal Article
Open access
PDF file
SNSean Naughton
Sean Naughton
URUrdhva Raval
Urdhva Raval
JHJoyce M. Harary
Joyce M. Harary
Giulio PasinettiGiulio Pasinetti
Giulio Pasinetti

7 December 2020 in Alzheimer's & Dementia
Verified
Journal Article
Closed access
PDF file
URUrdhva Raval
Urdhva Raval
EZEmma Zeng
Emma Zeng
GPGiulio Maria Maria Pasinetti
Giulio Maria Maria Pasinetti